First Patient Enrolled in U.S. IDE Study To Evaluate the Potential of New Device To Reduce Stroke Risk in Atrial Fibrillation Patients

Biosense Webster, Inc. Launches U.S. Clinical Study to Evaluate the Safety and Efficacy of the WaveCrest® Left Atrial Appendage Occlusion System IRVINE, Calif., Jan. 11, 2018 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson Medical De... Devices, Interventional Cardiology Biosense Webster, Johnson & Johnson, WaveCrest, Left Atrial Appendage Occlusion

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2043386

Source: HSMN NewsFeed - January 11, 2018 Category: Pharmaceuticals Source Type: news